Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial
We assessed the utility of raloxifene (60 mg/day) as an adjuvant treatment for cognitive symptoms in postmenopausal women with schizophrenia in a 24-week, double-blind, randomized, placebo-controlled study. Patients were recruited from the inpatient and outpatient services of Parc Sanitari Sant Joan de Déu, Hospital Universitari Institut Pere Mata, and Corporació Sanitària Parc Taulí. Seventy eight postmenopausal women with schizophrenia were randomized to either adjunctive raloxifene or placebo. Sixty-eight began the clinical trial (37 women on raloxifene adjunct) and 31 on placebo adjunct. The outcome measures were: memory, attention and executive function. Assessment was conducted at baseline and at week 24. Between groups homogeneity was tested with the Student's t test for continuous variables and/or the Mann–Whitney U test for ordinal variables and the χ2 test or Fisher's exact test for categorical variables. The differences between the two groups in neuropsychological test scores were compared using the Student's t test. The sample was homogenous with respect to age, formal education, illness duration and previous pharmacological treatment. The addition of raloxifene to antipsychotic treatment as usual showed no differences in cognitive function. The daily use of 60 mg raloxifene as an adjuvant treatment in postmenopausal women with schizophrenia has no appreciable effect.
ClinicalTrials.gov Identifier: NCT01573637.
KeywordsRaloxifene Schizophrenia Cognition Clinical trial
The Stanley Medical Research Institute (#10T-1392). The members of RALOPSYCAT Group are Carolina Rodríguez (nurse), Isabel Beneitez (psychiatrist), Joan Costa (clinician), Lourdes Castro (nurse), Silvia Teba (nurse), Laura Milian (nurse), Alexandrina Foix (nurse), Sonia Rivero (psychiatrist), Marian Cavero (psychiatrist), María Argemí (psychiatrist), Fernando Teba (psychiatrist), Belén Arranz (psychiatrist), Elena Rubio (psychiatrist), Marta Coromina (psychiatrist), Ángeles Santos (nurse), Jose Luis Bogas (nurse), Ana Barber (nurse), Carlota Romans (psychiatrist), Manel Márquez (psychiatrist), Anna Sabata (nurse), Lourdes Nieto (psychologist), Eva Willikens (psychologist), Enrich Blanch (nurse), Siddharta Acebillo (psychiatrist), Ramón Coronas (psychiatrist), Laura Ortega (nurse), Ignasi Coll (psychiatrist), Joaquín Valero (psychiatrist), Jesús Rodríguez (psychiatrist), Modesto Pérez (psychiatrist), Inés Niubó (psychiatrist), Montse Tost (psychologist), Mari Pau Monfort (pharmacist), Lourdes Martorell (biologist), Elisabet Vilella (biologist), Judith Usall (psychiatrist), Elena Huerta-Ramos (psychologist), Javier Labad (psychiatrist), Jesús Cobo (psychiatrist), Christian Núñez (psychologist), Marta Creus (psychologist), Gemma García-Parés (psychiatrist), Daniel Cuadras (statistical), José Franco (psychiatrist), Eva Miquel (pharmacist), Julio-César Reyes (psychiatrist), Mercedes Roca (psychiatrist).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- 4.Soria V, González-Rodríguez A, Huerta-Ramos E et al (2018) Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: a systematic review and narrative synthesis. Psychoneuroendocrinology. https://doi.org/10.1016/j.psyneuen.2018.04.012 CrossRefPubMedGoogle Scholar
- 8.Velázquez-Zamora DA, Garcia-Segura LM, González-Burgos I (2012) Effects of selective estrogen receptor modulators on allocentric working memory performance and on dendritic spines in medial prefrontal cortex pyramidal neurons of ovariectomized rats. Horm Behav 61:512–517. https://doi.org/10.1016/j.yhbeh.2012.01.010 CrossRefPubMedGoogle Scholar
- 10.Wong J, Seeman MV, Shapiro H (2003) Case report: raloxifene in postmenopausal women with psychosis: preliminary findings. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry 11(697):698Google Scholar
- 15.Ji E, Weickert CS, Lenroot R et al (2016) Adjunctive selective estrogen receptor modulator increases neural activity in the hippocampus and inferior frontal gyrus during emotional face recognition in schizophrenia. Transl Psychiatry 6:e795. https://doi.org/10.1038/tp.2016.59 CrossRefPubMedPubMedCentralGoogle Scholar
- 17.Kindler J, Weickert CS, Schofield PR et al (2016) Raloxifene increases prefrontal activity during emotional inhibition in schizophrenia based on estrogen receptor genotype. Eur Neuropsychopharmacol J Eur Coll Neuropsychopharmacol 26:1930–1940. https://doi.org/10.1016/j.euroneuro.2016.10.009 CrossRefGoogle Scholar
- 18.Weiser M, Levi L, Burshtein S et al (2017) Raloxifene plus antipsychotics versus placebo plus antipsychotics in severely ill decompensated postmenopausal women with schizophrenia or schizoaffective disorder. J Clin Psychiatry. https://doi.org/10.4088/JCP.15m10498 CrossRefPubMedPubMedCentralGoogle Scholar
- 21.Labad J, Martorell L, Huerta-Ramos E et al (2016) Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial. Eur Neuropsychopharmacol 26:1683–1689. https://doi.org/10.1016/j.euroneuro.2016.08.006 CrossRefPubMedGoogle Scholar
- 22.Bieber E, Sanfilippo JS, Horowitz IR, MIS (2006) Clinical gynecology. Cambridge University Press, PhiladelphiaGoogle Scholar
- 23.JAVA (2013) Declaration of Helsinki World Medical Association Declaration of Helsinki. Bull World Health Organ 79:373–374Google Scholar
- 27.Benedet MJ, Alexandre MA (1998) Test de Aprendizaje Verbal España-Complutense (TAVEC). TEA Ediciones, MadridGoogle Scholar
- 28.Moscovitch M, Umiltà C (1990) Modularity and neuropsychology: implications for the organization of attention and memory in normal and brain-damaged people. In: Schwartz MF (ed) Modular deficits in Alzheimer type dementia. MIT Press, CambridgeGoogle Scholar
- 29.Conners CK (2002) Conners’ Continuous Performance Test CPT-II. Technical Guide and Software Manual. Multi Health Systems, North Tonawanda, NYGoogle Scholar
- 34.Seisdedos N, Corral S, Cordero A, de la Cruz MVH, Pereña JMV (1999) WAIS III. Manual Técnico. TEA Ediciones, MadridGoogle Scholar
- 35.Strauss E, Sherman EMS, Spreen O (2006) A compendium of neuropsychological tests: administration, norms, and commentary, 3rd edn. Oxford University Press, New YorkGoogle Scholar
- 42.Vila È, Huerta-Ramos E, Núñez C et al (2018) Specificity proteins 1 and 4 in peripheral blood mononuclear cells in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial. Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-018-0938-7 CrossRefPubMedGoogle Scholar